Dextromethorphan-quinidine-responsive pseudobulbar affect (PBA): Psychopharmacological model for wide-ranging disorders of emotional expression?

4Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

The symptoms of emotional dysregulation associated with the syndrome known as pseudobulbar affect (PBA) can be effectively treated by the sigma, glutamate, and serotonergic agent dextromethorphan combined with quinidine. If the same brain circuits affected in PBA are also compromised in related disorders of emotional expression, dextromethorphan-quinidine and other novel sigma-glutamate-serotonin agents could prove to be novel psychopharmacologic treatments for these conditions as well.

Cite

CITATION STYLE

APA

Stahl, S. M. (2016). Dextromethorphan-quinidine-responsive pseudobulbar affect (PBA): Psychopharmacological model for wide-ranging disorders of emotional expression? CNS Spectrums, 21(6), 419–423. https://doi.org/10.1017/S1092852916000742

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free